7月16日午间公告一览：泰林生物控股股东协议转让1210万股完成过户登记

Core Viewpoint - The announcement details the transfer of 12.1 million shares (9.9836% of total share capital) from the controlling shareholder and actual controller Ye Daling to Ni Weiju, which has been completed as of July 15, 2025. The transfer does not involve any secondary market reduction and will not change the company's controlling shareholder or actual controller [1]. Summary by Categories - Share Transfer Details - Ye Daling transferred 12.1 million shares to Ni Weiju, representing 9.9836% of the company's total share capital [1]. - The transfer was completed on July 15, 2025, with the registration of the transfer [1]. - Commitment from New Shareholder - Ni Weiju has committed not to reduce the shares acquired through this transfer in any way for 12 months following the completion of the transfer [1]. - Impact on Company Control - The transfer does not involve any secondary market reduction and will not lead to a change in the company's controlling shareholder or actual controller [1].